Powered By Blogger

Dec 21, 2017

Health Ministry and ICMR launch India Hypertension Management Initiative (IHMI). Press Information Bureau, GOI MH&FW

Smt Preeti Sudan, Secretary (HFW) and Dr. Soumya Swaminathan, Secretary, DHR and DG, ICMR, launched the India Hypertension Management Initiative (IHMI) at a function, here today. The IHMI aims to reduce disability and death related to cardiovascular disease (CVD), the leading cause of death in India, by improving the control of high blood pressure (hypertension), reducing salt consumption and eliminating artificial trans-fats, leading risk factors for CVD. 


Smt. Preeti Sudan, Secretary (HFW), underlined the various aspects of the non-communicable diseases like prevention, detection and management. She stated that creating awareness about NCDs is vital as it is a silent disease. The Health Secretary further said that there is urgent need to raise awareness about NCDs amongst families regarding packaged food and processed foods with excessive salt and trans-fat. She also highlighted the need for incorporating yoga in one’s life for prevention and management of hypertension. 

Dr. Soumya Swaminathan, Secretary, DHR and DG, ICMR highlighted the importance of initiating and managing treatment for hypertension. She emphasized on the need for public education programme on nutrition and training of frontline healthcare workers regarding management of hypertension. She stated that the risk factors have to be managed at a very young age and we need to look into behavioral issues related to food intake, especially salt. 

Dr Henk Bekedam, WHO India Representative, highlighted the importance of awareness and detection of hypertension. He congratulated the Health Ministry and ICMR for this initiative and said that this programme will help with the management of hypertension in the country. 

The India Hypertension Management Initiative (IHMI) is a collaborative project of Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare (MoHFW), State Governments, World Health Organization (WHO), and Resolve to Save Lives initiative of Vital Strategies. The primary goal of this project is to reduce morbidity and mortality due to CVDs, the leading cause of death in India, by improving the control of high blood pressure, which is a leading risk factor for CVDs among adults in India. 

The IHMI is focused on five essential components of scalable treatment of hypertension. It will support the adoption of standardized simplified treatment plans for managing high blood pressure, ensure the regular and uninterrupted supply of quality-assured medications, task sharing so health workers who are accessible to patients can distribute medications already prescribed by the medical officer, and patient-centered services that reduce the barriers to treatment adherence. Data on hypertension will be improved through streamlined monitoring systems, and the lessons learned and practice-based evidence will inform further interventions to improve cardiovascular care. IHMI will be progressively rolled out in 25 districts in the first two years across districts selected by the Health Ministry for expansion of active screening and intensification of treatment activities for hypertension. 

Around 200 million adults in India have high blood pressure, yet control rates for the condition remain low. Studies suggest that in rural areas in India, only one quarter of people with hypertension are aware of their condition, and only around 10 percent have their blood pressure controlled. In urban areas, around 40 percent of people with hypertension are aware of their condition, and only around 20 percent have their blood pressure controlled. This initiative aims to strengthen the cardiovascular disease component of the Health Ministry’s National Program for Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS). It will focus on strengthening hypertension management and monitoring at the primary health care level, within the existing healthcare system, and is aligned with WHO’s Global HEARTS Initiative and National Guidelines. 

Also present at the event were Shri Manoj Jhalani (AS&MD, NHM), Dr BD Athani (Special DGHS) and Shri Pawan Aggarwal, CEO, FSSAI and Dr Alka Aggarwal Singh, Country Director, Vital Strategies along with the other senior officers of the Ministry and representatives of international development organizations. 

Press Information Bureau 
Government of India
Ministry of Health and Family Welfare
28-November-2017 20:09 IST

1 comment:

  1. Irrespective of receiving daily oral or future injectable depot therapies, these require health care visits for medication and monitoring of safety and response. If patients are treated early enough, before a lot of immune system damage has occurred, life expectancy is close to normal, as long as they remain on successful treatment. However, when patients stop therapy, virus rebounds to high levels in most patients, sometimes associated with severe illness because i have gone through this and even an increased risk of death. The aim of “cure”is ongoing but i still do believe my government made millions of ARV drugs instead of finding a cure. for ongoing therapy and monitoring. ARV alone cannot cure HIV as among the cells that are infected are very long-living CD4 memory cells and possibly other cells that act as long-term reservoirs. HIV can hide in these cells without being detected by the body’s immune system. Therefore even when ART completely blocks subsequent rounds of infection of cells, reservoirs that have been infected before therapy initiation persist and from these reservoirs HIV rebounds if therapy is stopped. “Cure” could either mean an eradication cure, which means to completely rid the body of reservoir virus or a functional HIV cure, where HIV may remain in reservoir cells but rebound to high levels is prevented after therapy interruption.Dr Itua Herbal Medicine makes me believes there is a hope for people suffering from,Parkinson's disease,Schizophrenia,Lung Cancer,Breast Cancer,psoriasis,Colo-Rectal Cancer,Blood Cancer,Prostate Cancer,siva.Fatal Familial Insomnia Factor V Leiden Mutation ,Epilepsy Dupuytren's disease,Desmoplastic small-round-cell tumor Diabetes ,Coeliac disease,Creutzfeldt–Jakob disease,Cerebral Amyloid Angiopathy, Ataxia,Arthritis,Amyotrophic Lateral Scoliosis,Fibromyalgia,Fluoroquinolone Toxicity
    Syndrome Fibrodysplasia Ossificans ProgresSclerosis,Alzheimer's disease,Adrenocortical carcinoma.Asthma,Allergic diseases.Hiv_ Aids,Herpe ,Copd,Glaucoma., Cataracts,Macular degeneration,Cardiovascular disease,Lung disease.Enlarged prostate,Osteoporosis.Alzheimer's disease,
    Dementia.(measles, tetanus, whooping cough, tuberculosis, polio and diphtheria),Chronic Diarrhea,
    Hpv,All Cancer Types,Diabetes,Hepatitis,I read about him online how he cure Tasha and Tara so i contacted him on drituaherbalcenter@gmail.com / . even talked on whatsapps +2348149277967 believe me it was easy i drank his herbal medicine for two weeks and i was cured just like that isn't Dr Itua a wonder man? Yes he is! I thank him so much so i will advise if you are suffering from one of those diseases Pls do contact him he's a nice man.

    ReplyDelete